Revolution Medicines, Inc. Basic Shares Outstanding (Weighted Average)
Revolution Medicines, Inc. (RVMD) reported Basic Shares Outstanding (Weighted Average) of 210.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 210.89M shares, a 11.83% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 198.10M shares, a 5.29% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 194.54M shares, a 11.66% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 189.23M shares, a 13.42% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 190.13M shares, a 13.35% increase from fiscal 2024.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 167.74M shares, a 48.24% increase from fiscal 2023.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 113.15M shares, a 40.34% increase from fiscal 2022.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 80.63M shares, a 10.74% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 210.89M shares 10-Q · filed 2026-08-05 | 204.53M shares 10-Q · filed 2026-08-05 | 201.18M shares derived: average of 3 quarters · filed 2026-08-05 | 198.19M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 198.10M shares 10-Q · filed 2026-05-06 | 196.32M shares derived: average of 2 quarters · filed 2026-05-06 | 193.96M shares derived: average of 3 quarters · filed 2026-05-06 | 192.61M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 194.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 191.89M shares derived: average of 2 quarters · filed 2026-02-25 | 190.79M shares derived: average of 3 quarters · filed 2026-08-05 | 190.13M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 189.23M shares 10-Q · filed 2025-11-05 | 188.91M shares derived: average of 2 quarters · filed 2026-08-05 | 188.66M shares 10-Q · filed 2025-11-05 | 185.05M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 188.58M shares 10-Q · filed 2026-08-05 | 188.37M shares 10-Q · filed 2026-08-05 | 183.65M shares derived: average of 3 quarters · filed 2026-08-05 | 179.45M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 188.15M shares 10-Q · filed 2026-05-06 | 181.18M shares derived: average of 2 quarters · filed 2026-05-06 | 176.40M shares derived: average of 3 quarters · filed 2026-05-06 | 173.59M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 174.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 170.53M shares derived: average of 2 quarters · filed 2026-02-25 | 168.74M shares derived: average of 3 quarters · filed 2026-02-25 | 167.74M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 166.84M shares 10-Q · filed 2025-11-05 | 165.99M shares derived: average of 2 quarters · filed 2025-11-05 | 165.58M shares 10-Q · filed 2025-11-05 | 159.55M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | 165.14M shares 10-Q · filed 2025-08-06 | 164.94M shares 10-Q · filed 2025-08-06 | 157.12M shares derived: average of 3 quarters · filed 2026-02-25 | 145.15M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | 164.73M shares 10-Q · filed 2025-05-07 | 153.11M shares derived: average of 2 quarters · filed 2026-02-25 | 138.48M shares derived: average of 3 quarters · filed 2026-02-25 | 130.58M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | 141.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 125.36M shares derived: average of 2 quarters · filed 2026-02-25 | 119.20M shares derived: average of 3 quarters · filed 2026-02-25 | 113.15M shares 10-K · filed 2026-02-25 |
| 2023-09-30 | 109.23M shares 10-Q · filed 2024-11-06 | 108.06M shares derived: average of 2 quarters · filed 2024-11-06 | 103.70M shares 10-Q · filed 2024-11-06 | 100.05M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 106.88M shares 10-Q · filed 2024-08-07 | 100.89M shares 10-Q · filed 2024-08-07 | 96.99M shares derived: average of 3 quarters · filed 2025-02-26 | 93.92M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 94.83M shares 10-Q · filed 2024-05-08 | 92.04M shares derived: average of 2 quarters · filed 2025-02-26 | 89.59M shares derived: average of 3 quarters · filed 2025-02-26 | 85.76M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 89.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 86.97M shares derived: average of 2 quarters · filed 2025-02-26 | 82.74M shares derived: average of 3 quarters · filed 2025-02-26 | 80.63M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 84.69M shares 10-Q · filed 2023-11-06 | 79.49M shares derived: average of 2 quarters · filed 2023-11-06 | 77.75M shares 10-Q · filed 2023-11-06 | 76.74M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | 74.28M shares 10-Q · filed 2023-08-08 | 74.22M shares 10-Q · filed 2023-08-08 | 74.09M shares derived: average of 3 quarters · filed 2024-02-26 | 73.95M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | 74.16M shares 10-Q · filed 2023-05-08 | 73.99M shares derived: average of 2 quarters · filed 2024-02-26 | 73.84M shares derived: average of 3 quarters · filed 2024-02-26 | 73.73M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | 73.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 73.68M shares derived: average of 2 quarters · filed 2024-02-26 | 73.59M shares derived: average of 3 quarters · filed 2024-02-26 | 72.81M shares 10-K · filed 2024-02-26 |
| 2021-09-30 | 73.54M shares 10-Q · filed 2022-11-07 | 73.47M shares derived: average of 2 quarters · filed 2022-11-07 | 72.47M shares 10-Q · filed 2022-11-07 | |
| 2021-06-30 | 73.40M shares 10-Q · filed 2022-08-09 | 71.92M shares 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | 54.87M shares 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |